Atlas Trials

Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877

Clinical trial NCT00471367 · TERMINATED

Trial details

NCT number
NCT00471367
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
LymphomaNHLNon-Hodgkin Lymphoma
Start date
2007-04-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.